Hospira, Inc. (NYSE: HSP)
Lake Forest, IL 60045 (Map) Phone: 224-212-2000
Fax: 224-212-3350
Toll Free: 877-946-7747
http://www.hospira.com
Overview
Hospira helps hospitals help the hurting. The company, a spinoff of drug manufacturer Abbott Laboratories, makes specialty injectable pharmaceuticals (primarily generics) and drug delivery equipment. Its medication delivery systems include drug pumps, infusion therapy devices, and related medication management software. Its injectable drugs include cardiovascular, anesthesia, and anti-infective therapies. In addition, Hospira provides contract manufacturing services for injectable pharmaceuticals. A good portion of Hospira's sales are to group purchasing organizations (GPOs), including Broadlane, Novation, and Premier.
Sample OverviewKey Numbers from Hoover's UK
Key financials for Hospira, Inc. (NYSE: HSP)
| Company Type | Public (NYSE: HSP) |
|---|---|
| Fiscal Year-End | December |
| 2010 Sales (mil.) | £2,532.1 |
| 1-Year Sales Growth | 1.0% |
| 2010 Net Income (mil.) | £230.9 |
| 1-Year Net Income Growth | (11.6%) |
| 2010 Employees | 14,000 |
| 1-Year Employee Growth | 3.7% |
Key People from Hoover's UK
Key people and executives for Hospira, Inc. (NYSE: HSP)
| Chairman | Christopher B. (Chris) Begley (Subscribers see complete biographies -- view sample)
|
|---|---|
| CEO and Director | F. Michael (Mike) Ball |
| SVP Operations | James H. (Jim) Hardy Jr. |
Top Competitors from Hoover's UK
Top competitors of Hospira, Inc. (NYSE: HSP)
There are 15 competitors for Hospira; see more.Significant Developments
View company events at Hospira, Inc. (NYSE: HSP) such as IPOs, bankruptcies, or executive changes
| Event | Details |
|---|---|
| Top Executive Change | Subscribers get full details -- view a sample |
| Top Executive Change |
Industry Information from Hoover's UK
First Research Industry Profiles Extensive Industry Intelligence
Hoover's Industries
- Pharmaceuticals(primary)
Rankings from Hoover's UK
See how Hospira, Inc. (NYSE: HSP) ranks in standard industry listings such as Fortune 500, S&P 500, and Dow Jones
- S&P 500
- #544 in FORTUNE 1000 (May 2011)

